Polymers with platinum drugs and other macromolecular metal complexes for cancer treatment

Progress in Polymer Science

Volumn 39, Issue 9, 2014, Pages 1614-1643

  Callari, Manuela ^a,b,c   Aldrich Wright, Janice R ^a   De Souza, Paul L ^b   Stenzel, Martina H ^c  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Drug delivery; Macromolecular metal complex; Metal drugs; Micelles; Nanoparticle; Platinum drugs

Indexed keywords

CONJUGATED POLYMERS; DISEASES; DRUG DELIVERY; DRUG PRODUCTS; LIGANDS; MACROMOLECULES; METAL COMPLEXES; METALS; MICELLES; NANOPARTICLES; PLATINUM; PLATINUM COMPOUNDS; CONTROLLED DRUG DELIVERY; DRUG INTERACTIONS; METAL NANOPARTICLES;

DRUG DELIVERY CARRIER; IMAGING PROPERTIES; INORGANIC NANOPARTICLE; METAL DRUGS; PLATINUM DRUGS; POLYMERIC NANOPARTICLES; SURFACE DECORATION; TARGETING LIGANDS;

DRUG INTERACTIONS; TARGETED DRUG DELIVERY;

EID: 84906225829     PISSN: 00796700     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.progpolymsci.2014.05.002     Document Type: Review

References (136)

1. Z.J. Guo, and P.J. Sadler Metals in medicine Angew Chem Int Ed 38 1999 1513 1531
2. N.J. Wheate, S. Walker, G.E. Craig, and R. Oun The status of platinum anticancer drugs in the clinic and in clinical trials Dalton Trans 39 2010 8113 8127
3. L. Kelland The resurgence of platinum-based cancer chemotherapy Nat Rev Cancer 7 2007 573 584
4. S.H. van Rijt, and P.J. Sadler Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs Drug Discovery Today 14 2009 1089 1097
5. A.V. Klein, and T.W. Hambley Platinum drug distribution in cancer cells and tumors Chem Rev 109 2009 4911 4920
6. C.G. Hartinger, M.A. Jakupec, S. Zorbas-Seifried, M. Groessl, A. Egger, W. Berger, H. Zorbas, P.J. Dyson, and B.K. Keppler KP1019, a new redox-active anticancer agent - preclinical development and results of a clinical phase I study in tumor patients Chem Biodivers 5 2008 2140 2155
7. P.J. Barnard, and S.J. Berners-Price Targeting the mitochondrial cell death pathway with gold compounds Coord Chem Rev 251 2007 1889 1902
8. F. Danhier, O. Feron, and V. Préat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J Control Release 148 2010 135 146
9. S. Bisht, and A. Maitra Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy Wiley Interdiscip Rev Nanomed Nanobiotechnol 1 2009 415 425
10. A.V. Ambade, E.N. Savariar, and S. Thayumanavan Dendrimeric micelles for controlled drug release and targeted delivery Mol Pharm 2 2005 264 272
11. B. Schechter, A. Neumann, M. Wilchek, and R. Arnon Soluble polymers as carriers of cis-platinum J Control Release 10 1989 75 87
12. Y. Kim, M.H. Pourgholami, D.L. Morris, and M.H. Stenzel An optimized RGD-decorated micellar drug delivery system for albendazole for the treatment of ovarian cancer: from RAFT polymer synthesis to cellular uptake Macromol Biosci 11 2011 219 233
13. I.H.L. Hamelers, and A.I.P.M. de Kroon Nanocapsules a novel formulation technology for platinum-based anticancer drugs Future Lipidol 2 2007 445 453
14. M.S. Newman, G.T. Colbern, P.K. Working, C. Engbers, and M.A. Amantea Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice Cancer Chemother Pharmacol 43 1999 1 7
15. A.I.P.M. de Kroon, R.W.H.M. Staffhorst, B.D. Kruijff, and K.N.J. Burger Cisplatin nanocapsules Methods Enzymol 391 2005 118 125
16. K.N.J. Burger, R.W.H.M. Staffhorst, H.C. de Vijlder, M.J. Velinova, P.H. Bomans, P.M. Frederik, and B. de Kruijff Nanocapsules lipid-coated aggregates of cisplatin with high cytotoxicity Nat Med 8 2002 81 84
17. T. Dragovich, D. Mendelson, S. Kurtin, K. Richardson, D. Von Hoff, and A. Hoos A Phase 2 trial of the liposomal DACH platinum l-NDDP in patients with therapy-refractory advanced colorectal cancer Cancer Chemother Pharmacol 58 2006 759 764
18. T. Peleg-Shulman, D. Gibson, R. Cohen, R. Abra, and Y. Barenholz Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance Biochim Biophys Acta 1510 2001 278 291
19. K.F. Pirollo, and E.H. Chang Does a targeting ligand influence nanoparticle tumor localization or uptake? Trends Biotechnol 26 2008 552 558
20. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int J Nanomed 1 2006 297 315
21. K.J. Harrington, C.R. Lewanski, A.D. Northcote, J. Whittaker, H. Wellbank, R.G. Vile, A.M. Peters, and J.S.W. Stewart Phase I-II study of pegylated liposomal cisplatin (SPI-077 (TM)) in patients with inoperable head and neck cancer Ann Oncol 12 2001 493 496
22. W.C. Zamboni, A.C. Gervais, M.J. Egorin, J.H. Schellens, E.G. Zuhowski, D. Pluim, E. Joseph, D.R. Hamburger, P.K. Working, G. Colbern, M.E. Tonda, D.M. Potter, and J.L. Eiseman Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma Cancer Chemother Pharmacol 53 2004 329 336
23. G.P. Stathopoulos Liposomal cisplatin: a new cisplatin formulation Anticancer Drugs 21 2010 732 736
24. M.I. Koukourakis, A. Giatromanolaki, M. Pitiakoudis, G. Kouklakis, P. Tsoutsou, I. Abatzoglou, M. Panteliadou, K. Sismanidou, E. Sivridis, and T. Boulikas Concurrent liposomal cisplatin (Lipoplatin), 5-fluorouracil and radiotherapy for the treatment of locally advanced gastric cancer: a phase I/II study Int J Radiat Oncol Biol Phys 78 2010 150 155
25. C. Arienti, A. Tesei, A. Ravaioli, M. Ratta, S. Carloni, S. Mangianti, P. Ulivi, S. Nicoletti, D. Amadori, and W. Zoli Activity of lipoplatin in tumor and in normal cells in vitro Anticancer Drugs 19 2008 983 990
26. N. Mylonakis, A. Athanasiou, N. Ziras, J. Angel, A. Rapti, S. Lampaki, N. Politis, C. Karanikas, and C. Kosmas Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer Lung Cancer 68 2010 240 247
27. J. Kreuter Nanoparticles and microparticles for drug and vaccine delivery J Anat 189 1996 503 505
28. E. Cohen-Sela, M. Chorny, N. Koroukhov, H.D. Danenberg, and G. Golomb A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles J Control Release 133 2009 90 95
29. K. Avgoustakis, A. Beletsi, Z. Panagi, P. Klepetsanis, G. Karydas, and D.S. Ithakissios PLGA-mPEG nanoparticles of cisplatin in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties J Control Release 79 2002 123 135
30. D. Moreno, S. Zalba, I. Navarro, C. Tros de Ilarduya, and M.J. Garrido Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice Eur J Pharm Biopharm 74 2010 265 274
31. V.R. Sinha, A.K. Singla, S. Wadhawan, R. Kaushik, R. Kumria, K. Bansal, and S. Dhawan Chitosan microspheres as a potential carrier for drugs Int J Pharm 274 2004 1 33
32. J.H. Kim, Y.S. Kim, K. Park, S. Lee, H.Y. Nam, K.H. Min, H.G. Jo, J.H. Park, K. Choi, S.Y. Jeong, R.W. Park, I.S. Kim, K. Kim, and I.C. Kwon Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice J Control Release 127 2008 41 49
33. Z. Yang, X. Wang, H. Diao, J. Zhang, H. Li, H. Sun, and Z. Guo Encapsulation of platinum anticancer drugs by apoferritin Chem Commun 2007 3453 3455
34. R. Xing, X. Wang, C. Zhang, Y. Zhang, Q. Wang, Z. Yang, and Z. Guo Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin J Inorg Biochem 103 2009 1039 1044
35. W.H. Ang, I. Khalaila, C.S. Allardyce, L. Juillerat-Jeanneret, and P.J. Dyson Rational design of platinum(IV) compounds to overcome glutathione-S- transferase mediated drug resistance J Am Chem Soc 127 2005 1382 1383
36. S. Aryal, C.M.J. Hu, V. Fu, and L. Zhang Nanoparticle drug delivery enhances the cytotoxicity of hydrophobic-hydrophilic drug conjugates J Mater Chem 22 2012 994 999
37. M.L. Manunta, E. Gavini, G. Chessa, E.S. Passino, G.M. Careddu, S. Giua, A. Mollica, M.P. Demontis, A. Leoni, and P. Muzzetto Carboplatin sustained delivery system using injectable microspheres J Vet Med Ser A: Physiol Pathol Clin Med 52 2005 416 422
38. A. Matsumoto, Y. Matsukawa, T. Suzuki, and H. Yoshino Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co- glycolide) and poly(dl-lactide) J Control Release 106 2005 172 180
39. A. Matsumoto, Y. Matsukawa, T. Suzuki, H. Yoshino, and M. Kobayashi The polymer-alloys method as a new preparation method of biodegradable microspheres principle and application to cisplatin-loaded microspheres J Control Release 48 1997 19 27
40. H. Araki, T. Tani, and M. Kodama Antitumor effect of cisplatin incorporated into polylactic acid microcapsules Artif Organs 23 1999 161 168
41. R. Verrijk, I.J.H. Smolders, J.G. Mevie, and A.C. Begg Polymer-coated albumin microspheres as carriers for intravascular tumour targeting of cisplatin Cancer Chemother Pharmacol 29 1991 117 121
42. M. Shive, and J. Anderson Biodegradation and biocompatibility of PLA and PLGA microspheres Adv Drug Deliv Rev 28 1997 5 24
43. S. Dhar, F.X. Gu, R. Langer, O.C. Farokhzad, and S.J. Lippard Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles Proc Natl Acad Sci USA 105 2008 17356 17361
44. N. Kolishetti, S. Dhar, P.M. Valencia, L.Q. Lin, R. Karnik, S.J. Lippard, R. Langer, and O.C. Farokhzad Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy Proc Natl Acad Sci USA 107 2010 17939 17944
45. V.B. Jadhav, Y.J. Jun, J.H. Song, M.K. Park, J.H. Oh, S.W. Chae, I.S. Kim, S.J. Choi, H.J. Lee, and Y.S. Sohn A novel micelle-encapsulated platinum(II) anticancer agent J Control Release 147 2010 144 150
46. Y.J. Jun, U.S. Toti, H.Y. Kim, J.Y. Yu, B. Jeong, M.J. Jun, and Y.S. Sohn Thermoresponsive micelles from oligopeptide-grafted cyclotriphosphazenes Angew Chem Int Ed Engl 45 2006 6173 6176
47. U.S. Toti, S.H. Moon, H.Y. Kim, Y.J. Jun, B.M. Kim, Y.M. Park, B. Jeong, and Y.S. Sohn Thermosensitive and biocompatible cyclotriphosphazene micelles J Control Release 119 2007 34 40
48. P. Xu, E.A. Van Kirk, W.J. Murdoch, Y. Zhan, D.D. Isaak, M. Radosz, and Y. Shen Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles Biomacromolecules 7 2006 829 835
49. V. Cucinotta, A. Mangano, G. Nobile, A.M. Santoro, and G. Vecchio New platinum(II) complexes of beta-cyclodextrin diamine derivatives and their antitumor activity J Inorg Biochem 52 1993 183 190
50. A.M. Krause-Heuer, N.J. Wheate, M.J. Tilby, D.G. Pearson, C.J. Ottley, and J.R. Aldrich-Wright Substituted beta-cyclodextrin and calix4arene as encapsulatory vehicles for platinum(II)-based DNA intercalators Inorg Chem 47 2008 6880 6888
51. P. Ferruti, E. Ranucci, F. Trotta, E. Gianasi, E.G. Evagorou, M. Wasil, G. Wilson, and R. Duncan Synthesis, characterisation and antitumour activity of platinum(II) complexes of novel functionalised poly(amido amine)s Macromol Chem Phys 200 1999 1644 1654
52. M. Adeli, F. Hakimpoor, M. Parsamanesh, M. Kalantari, Z. Sobhani, and F. Attyabi Quantum dot-pseudopolyrotaxane supramolecules as anticancer drug delivery systems Polymer 52 2011 2401 2413
53. K.J. Haxton, and H.M. Burt Polymeric drug delivery of platinum-based anticancer agents J Pharm Sci 98 2009 2299 2316
54. L.L. Komane, E.H. Mukaya, E.W. Neuse, and C.E.J. Rensburg Macromolecular antiproliferative agents featuring dicarboxylato-chelated platinum J Inorg Organometallic Polym Mater 18 2007 111 123
55. N. Nishiyama, S. Okazaki, H. Cabral, M. Miyamoto, Y. Kato, Y. Sugiyama, K. Nishio, Y. Matsumura, and K. Kataoka Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice cancer Res Cancer Res 63 2003 8977 8983
56. N. Nishiyama, M. Yokoyama, T. Aoyagi, T. Okano, Y. Sakurai, and K. Kataoka Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichlorodiammineplatinum(ii) and poly(ethylene glycol)-poly(α, β-aspartic acid) block copolymer in an aqueous medium Langmuir 15 1999 377 383
57. R. Perez-solerl, I. Hanl, S. Ai-baker, and A.R. Khokhar Lipophilic platinum complexes entrapped in liposomes improved stability and preserved antitumor activity with complexes containing linear alkyl carboxylato leaving grouos Cancer Chemother Pharmacol 33 1994 378 384
58. N. Nishiyama, Y. Kato, Y. Sugiyama, and K. Kataoka Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system Pharm Res 18 2001 1035 1041
59. Y. Mizumura, Y. Matsumura, T. Hamaguchi, N. Nishiyama, and K. Kataoka Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity Jpn J Cancer Res 92 2001 328 336
60. N. Nishiyama, F. Koizumi, S. Okazaki, and Y. Matsumura Differential gene expression profile between PC-14 cells treated with free cisplatin and cisplatin-incorporated polymeric micelles Bioconjug Chem 14 2003 449 457
61. H. Uchino, Y. Matsumura, T. Negishi, F. Koizumi, T. Hayashi, T. Honda, N. Nishiyama, K. Kataoka, S. Naito, and T. Kakizoe Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats Br J Cancer 93 2005 678 687
62. M. Baba, Y. Matsumoto, A. Kashio, H. Cabral, N. Nishiyama, K. Kataoka, and T. Yamasoba Micellization of cisplatin (NC-6004) reduces its ototoxicity in guinea pigs J Control Release 157 2012 112 117
63. K. Endo, T. Ueno, S. Kondo, N. Wakisaka, S. Murono, M. Ito, K. Kataoka, Y. Kato, and T. Yoshizaki Tumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinoma Cancer Sci 104 2013 369 374
64. R. Plummer, R.H. Wilson, H. Calvert, A.V. Boddy, M. Griffin, J. Sludden, M.J. Tilby, M. Eatock, D.G. Pearson, C.J. Ottley, Y. Matsumura, K. Kataoka, and T. Nishiya A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours Br J Cancer 104 2011 593 598
65. H. Cabral, N. Nishiyama, S. Okazaki, H. Koyama, and K. Kataoka Preparation and biological properties of dichloro(1,2-diaminocyclohexane) platinum(II) (DACHPt)-loaded polymeric micelles J Control Release 101 2005 223 232
66. E. Gianasi, M. Wasil, E.G. Evagorou, A. Keddle, G. Wilson, R. Duncan, L. Wcn, G.W. Group, and G.B. Suite HPMA copolymer platinates as novel antitumour agents in vitro properties, pharmacokinetics and antitumour activity in vivo Eur J Cancer 35 1999 994 1002
67. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature the key role of tumor-selective macromolecular drug targeting Adv Enzyme Regul 41 2001 189 207
68. J.M. Rademaker-Lakhai, C. Terret, S.B. Howell, C.M. Baud, R.F. De Boer, D. Pluim, J.H. Beijnen, J.H. Schellens, and J.P. Droz A phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors Clin Cancer Res 10 2004 3386 3395
69. X. Lin, Q. Zhang, J.R. Rice, D.R. Stewart, D.P. Nowotnik, and S.B. Howell Improved targeting of platinum chemotherapeutics Eur J Cancer 40 2004 291 297
70. M.M. Tibben, J.M. Rademaker-Lakhai, J.R. Rice, D.R. Stewart, J.H. Schellens, and J.H. Beijnen Determination of total platinum in plasma and plasma ultrafiltrate, from subjects dosed with the platinum-containing N-(2-hydroxypropyl)methacrylamide copolymer AP5280, by use of graphite-furnace Zeeman atomic-absorption spectrometry Anal Bioanal Chem 373 2002 233 236
71. P. Sood, K.B. Thurmond, J.E. Jacob, L.K. Waller, G.O. Silva, D.R. Stewart, and D.P. Nowotnik Synthesis and characterization of AP5346, a novel polymer-linked diaminocyclohexyl platinum chemotherapeutic agent Bioconjug Chem 2006 1270 1279
72. J.R. Rice, J.L. Gerberich, D.P. Nowotnik, and S.B. Howell Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system Clin Cancer Res 12 2006 2248 2254
73. M. Campone, J.M. Rademaker-Lakhai, J. Bennouna, S.B. Howell, D.P. Nowotnik, J.H. Beijnen, and J.H. Schellens Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients Cancer Chemother Pharmacol 60 2007 523 533
74. S.C. Song, C.O. Lee, and Y.S. Sohn A novel polymeric conjugate carrying two different anticancer drugs Polym Int 48 1999 627 629
75. Y.S. Sohn, H. Baek, Y.H. Cho, Y.A. Lee, O.S. Jung, C.O. Lee, and Y.S. Kim Synthesis and antitumor activity of novel polyphosphazene-(diamine)platinum(II) conjugates Int J Pharm 153 1997 79 91
76. Y.J. Jun, J.I. Kim, M.J. Jun, and Y.S. Sohn Selective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugates J Inorg Biochem 99 2005 1593 1601
77. R. Song, Y.J. Jun, J.I. Kim, C. Jin, and Y.S. Sohn Synthesis, characterization, and tumor selectivity of a polyphosphazene-platinum(II) conjugate J Control Release 105 2005 142 150
78. V.T. Huynh, G.J. Chen, P. de Souza, and M.H. Stenzel Thiol-yne and Thiol-ene "Click" chemistry as a tool for a variety of platinum drug delivery carriers, from statistical copolymers to crosslinked micelles Biomacromolecules 12 2011 1738 1751
79. V.T. Huynh, J.Y. Quek, P.L. de Souza, and M.H. Stenzel Block copolymer micelles with pendant bifunctional chelator for platinum drugs: effect of spacer length on the viability of tumor cells Biomacromolecules 13 2012 1010 1023
80. V.T. Huynh, P. de Souza, and M.H. Stenzel Polymeric micelles with pendant dicarboxylato chelating ligands prepared via a michael addition forcis-platinum drug delivery Macromolecules 44 2011 7888 7900
81. Y. Xue, X. Tang, J. Huang, X. Zhang, J. Yu, Y. Zhang, and S. Gui Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-alpha,beta-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice Colloids Surf B 85 2011 280 288
82. Y. Kim, M.H. Pourgholami, D.L. Morris, and M.H. Stenzel Effect of cross-linking on the performance of micelles as drug delivery carriers: a cell uptake study Biomacromolecules 13 2012 814 825
83. F.W. Zhang, M. Elsabahy, S.Y. Zhang, L.Y. Lin, J. Zou, and K.L. Wooley Shell crosslinked knedel-like nanoparticles for delivery of cisplatin: effects of crosslinking Nanoscale 5 2013 3220 3225
84. J. Xu, Q. Fu, J.M. Ren, G. Bryant, and G.G. Qiao Novel drug carriers: from grafted polymers to cross-linked vesicles Chem Commun 49 2013 33 35
85. K. Osada, H. Cabral, Y. Mochida, S. Lee, K. Nagata, T. Matsuura, M. Yamamoto, Y. Anraku, A. Kishimura, N. Nishiyama, and K. Kataoka Bioactive polymeric metallosomes self-assembled through block copolymer-metal complexation J Am Chem Soc 134 2012 13172 13175
86. P. Holister, C.R. Vas, and T. Harper Dendrimers Technology White Papers nr6 - cientifica 3 2003 1 11
87. C.J. Hawker, and J.M. Frechet Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules J Am Chem Soc 112 1990 7638 7647
88. D.A. Tomalia, L.A. Reyna, and S. Svenson Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging Biochem Soc Trans 35 2007 61-37
89. N. Malik, E.G. Evagorou, and R. Duncan Dendrimer-platinate: a novel approach to cancer chemotherapy Anticancer Drugs 10 1999 767 776
90. L.E. Gerweck, S. Vijayappa, and S. Kozin Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics Mol Cancer Ther 5 2006 1275 1279
91. I. Haririan, M.S. Alavidjeh, M.R. Khorramizadeh, M.S. Ardestani, Z.Z. Ghane, and H. Namazi Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines Int J Nanomed 5 2010 63 75
92. M.J. Pisani, N.J. Wheate, F.R. Keene, J.R. Aldrich-Wright, and J.G. Collins Anionic PAMAM dendrimers as drug delivery vehicles for transition metal-based anticancer drugs J Inorg Biochem 103 2009 373 380
93. G.J. Kirkpatrick, J.A. Plumb, O.B. Sutcliffe, D.J. Flint, and N.J. Wheate Evaluation of anionic half generation 5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin J Inorg Biochem 105 2011 1115 1122
94. G. Chen, J. Kumar, A. Gregory, and M.H. Stenzel Efficient synthesis of dendrimers via a thiol-yne and esterification process and their potential application in the delivery of platinum anti-cancer drugs Chem Commun 2009 6291 6293
95. J. Kim, H.J. Yoon, S. Kim, K. Wang, T. Ishii, Y.R. Kim, and W.D. Jang Polymer-metal complex micelles for the combination of sustained drug releasing and photodynamic therapy J Mater Chem 19 2009 4627 4631
96. Y. Xiong, W. Jiang, Y. Shen, H. Li, C. Sun, A. Ouahab, and J. Tu A poly(gamma, l-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery Biomaterials 33 2012 7182 7193
97. C. Huang, K.G. Neoh, L. Xu, E.T. Kang, and E. Chiong Polymeric nanoparticles with encapsulated superparamagnetic iron oxide and conjugated cisplatin for potential bladder cancer therapy Biomacromolecules 13 2012 2513 2520
98. M. Adeli, F. Hakimpoor, M. Ashiri, R. Kabiri, and M. Bavadi Anticancer drug delivery systems based on noncovalent interactions between carbon nanotubes and linear-dendritic copolymers Soft Matter 7 2011 4062 4070
99. S.D. Brown, P. Nativo, J.A. Smith, D. Stirling, P.R. Edwards, B. Venugopal, D.J. Flint, J.A. Plumb, D. Graham, and N.J. Wheate Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin J Am Chem Soc 132 2010 4678 4684
100. G.E. Craig, S.D. Brown, D.A. Lamprou, D. Graham, and N.J. Wheate Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval? Inorg Chem 51 2012 3490 3497
101. V.T. Huynh, S. Pearson, J.M. Noy, A. Abboud, R.H. Utama, H. Lu, and M.H. Stenzel Nanodiamonds with surface grafted polymer chains as vehicles for cell imaging and cisplatin delivery: enhancement of cell toxicity by POEGMEMA coating ACS Macro Lett 2 2013 246 250
102. J. Cha, W.B. Lee, C.R. Park, Y.W. Cho, C.H. Ahn, and I.C. Kwon Preparation and characterization of cisplatin-incorporated chitosan hydrogels, microparticles, and nanoparticles Macromol Res 14 2006 573 578
103. W. Gu, M. Gaborieau, V.T. Huynh, P.L. de Souza, and M.H. Stenzel Functionalization of microspheres with malonates using Michael Addition as a pathway to create a drug delivery system for platinum drugs for the treatment of liver cancer Polymer 52 2011 5993 6002
104. E.W. Neuse, and G. Caldwell cis-Diaminedichloroplatinum(II) complexes reversibly linked into the main chain of water-soluble polyamides J Inorg Organomet Polym Mater 7 1997 163 181
105. E.W. Neuse Carrier-bound platinum and iron compounds with carcinostatic properties Polym Adv Technol 793 1998 786 793
106. M.T. Johnson, E.W. Neuse, C.E.J. van Rensburg, and E. Kreft Cell growth-inhibiting properties of selected platinum(II) compounds J Inorg Organomet Polym Mater 13 2003 55 67
107. G. Caldwell, E.W. Neuse, and C.E.J. van Rensburg Cytotoxic activity of two polyaspartamidebased monoamineplatinum(II) conjugates against the HeLa cancer cell line Appl Organomet Chem 13 1999 189 194
108. W.C. Shen, K. Beloussow, M.G. Meirim, E.W. Neuse, and G. Caldwell Antiproliferative activity of polymer-bound, monoamine-coordinated platinum complexes against LNCaP human metastatic prostate adenocarcinoma cells J Inorg Organomet Polym Mater 10 2000 51 60
109. B. Schechter, G. Caldwell, M.G. Meirim, and E.W. Neuse Preliminary toxicological studies of selected water-soluble polymer-platinum conjugates Appl Organomet Chem 14 2000 701 708
110. E.W. Neuse, N. Mphephu, H.M. Netshifhefhe, and M.T. Johnson Synthesis and preliminary in vitro evaluation of polymeric dicarboxylato- and dihydroxylatoplatinum(II) chelates as antiproliferative agents Polym Adv Technol 13 2002 884 894
111. J.R. Tauro, and R.A. Gemeinhart Development of amine-containing polymeric particles J Biomater Sci 16 2005 1233 1244
112. J. Karim, S. Binauld, W. Scarano, and M.H. Stenzel Macromolecular platinum-drugs based on statistical and block copolymer structures and their DNA binding ability Polym Chem 4 2013 5542 5554
113. S. Binauld, W. Scarano, and M.H. Stenzel pH-Triggered release of platinum drugs conjugated to micelles via an acid-cleavable linker Macromolecules 45 2012 6989 6999
114. E. Bellis, L. Hajba, B. Kovacs, K. Sandor, L. Kollar, and G. Kokotos Three generations of alpha, gamma-diaminobutyric acid modified poly(propyleneimine) dendrimers and their cisplatin-type platinum complexes J Biochem Biophys Methods 69 2006 151 161
115. T. Kapp, A. Dullin, and R. Gust Platinum(II)-dendrimer conjugates synthesis and investigations on cytotoxicity, cellular distribution, platinum release, DNA, and protein binding Bioconjug Chem 21 2010 328 337
116. H.T.T. Duong, V.T. Huynh, P. de Souza, and M.H. Stenzel Core-cross-linked micelles synthesized by clicking bifunctional Pt(IV) anticancer drugs to isocyanates Biomacromolecules 11 2010 2290 2299
117. W. Scarano, H.T.T. Duong, H. Lu, P.L. De Souza, and M.H. Stenzel Folate conjugation to polymeric micelles via boronic acid ester to deliver platinum drugs to ovarian cancer cell lines Biomacromolecules 14 2013 962 975
118. H. Song, H. Xiao, Y. Zhang, H. Cai, R. Wang, Y. Zheng, Y. Huang, Y. Li, Z. Xie, T. Liu, and X. Jing Multifunctional Pt(IV) pro-drug and its micellar platform: to kill two birds with one stone J Mater Chem B 1 2013 762
119. H. Xiao, L. Yan, Y. Zhang, R. Qi, W. Li, R. Wang, S. Liu, Y. Huang, Y. Li, and X. Jing A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy Chem Commun 48 2012 10730 10732
120. S. Binauld, and M.H. Stenzel Acid-degradable polymers for drug delivery: a decade of innovation Chem Commun 49 2013 2082 2102
121. J. Yang, W. Liu, M. Sui, J. Tang, and Y. Shen Platinum(IV)-coordinate polymers as intracellular reduction-responsive backbone-type conjugates for cancer drug delivery Biomaterials 32 2011 9136 9143
122. S. Dhar, Z. Liu, J. Thomale, H. Dai, and S.J. Lippard Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device J Am Chem Soc 130 2008 11467 11476
123. S. Dhar, W.L. Daniel, D.A. Giljohann, C.A. Mirkin, and S.J. Lippard Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads J Am Chem Soc 2010 14652 14653
124. Y. Min, C. Mao, D. Xu, J. Wang, and Y. Liu Gold nanorods for platinum based prodrug delivery Chem Commun 46 2010 8424 8426
125. 3+ nanoparticles for targeted drug delivery and up-conversion cell imaging Adv Healthcare Mater 2 2013 562 567
126. D. Zhou, H. Xiao, F. Meng, S. Zhou, J. Guo, X. Li, X. Jing, and Y. Huang Layer-by-layer assembled polypeptide capsules for platinum-based pro-drug delivery Bioconjug Chem 23 2012 2335 2343
127. A.B.J. Withey, G.J. Chen, T.L.U. Nguyen, and M.H. Stenzel Macromolecular cobalt carbonyl complexes encapsulated in a click-cross-linked micelle structure as a nanoparticle to deliver cobalt pharmaceuticals Biomacromolecules 10 2009 3215 3226
128. I. Ott, K. Schmidt, B. Kircher, P. Schumacher, T. Wiglenda, and R. Gust Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action J Med Chem 48 2004 622 629
129. S. Pearson, W. Scarano, and M.H. Stenzel Micelles based on gold-glycopolymer complexes as new chemotherapy drug delivery agents Chem Commun 48 2012 4695 4697
130. M. Ahmed, S. Mamba, X.H. Yang, J. Darkwa, P. Kumar, and R. Narain Synthesis and evaluation of polymeric gold glyco-conjugates as anti-cancer agents Bioconjug Chem 24 2013 979 986
131. B.M. Blunden, D.S. Thomas, and M.H. Stenzel Macromolecular ruthenium complexes as anti-cancer agents Polym Chem 3 2012 2964 2975
132. B. Blunden, H. Lu, and M.H. Stenzel Enhanced delivery of the ruthenium drug RAPTA-C as macromolecular chemotherapeutics by conjugation to degradable polymeric micelles Biomacromolecules 14 2013 4177 4188
133. B.M. Blunden, A. Rawal, H. Lu, and M.H. Stenzel Superior chemotherapeutic benefits from the ruthenium-based anti-metastatic drug NAMI-A through conjugation to polymeric micelles Macromolecules 47 2014 1646 1655
134. D.P. Nowotnik, and E. Cvitkovic ProLindac (AP5346): a review of the development of an HPMA DACH platinum polymer therapeutic Adv Drug Deliv Rev 61 2009 1214 1219
135. K. Kitajima, M. Fukuoka, S. Kobayashi, Y. Kusunoki, M. Takada, S. Negoro, K. Matsui, N. Sakai, S. Ryu, and N. Takifuji Studies on the appropriate administration of cisplatin based on pharmacokinetics and toxicity Gan To Kagaku Ryoho 14 1987 2517 2523
136. T. Boulikas Clinical overview on lipoplatin: a successful liposomal formulation of cisplatin Expert Opin Investig Drugs 18 2009 1197 1218